MetaTOC stay on top of your field, easily

Serum metabolic profile at clinical onset as predictor of multiple sclerosis activity and progression after 5 years

, , , , , , , , , , , , ,

Multiple Sclerosis Journal

Published online on

Abstract

Multiple Sclerosis Journal, Ahead of Print.
Background:Metabolic dysregulations have been reported in multiple sclerosis (MS), but it is unclear whether metabolic profiles at disease onset predict long-term outcomes.Objectives:We evaluated whether baseline metabolic profiles at MS onset could ...